Related Experiment Videos
Integration of genomic technologies for accelerated cancer drug development
Mark Basik1, Spyro Mousses, Jeffrey Trent
1Translational Genomics Research Institute, Gaithersburg, MD, USA.
Abstract:
New technologies have greatly increased the scientist's ability to investigate complex molecular interactions that occur in cancer development and to identify genetic alterations and drug targets. However, these new capabilities have not accelerated drug development efforts; rather, they may be contributing to increased research and development costs because the large number of new drug targets discovered through genomics need to be investigated in great detail to characterize their putative functional involvement in the disease process. One solution to this bottleneck in functional analysis is the use of high-throughput technologies to produce efficient processes that can rapidly handle the large flood of information at every stage of disease. This review examines the use of new and emerging DNA, tissue, and live-cell transfection microarray technologies that can be used to discover, validate, and translate information resulting from the completion of the Human Genome Project.
Insights
New genomic technologies offer insights into cancer but create bottlenecks. High-throughput microarray technologies can accelerate the analysis of genetic alterations and drug targets for cancer development.
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Biotechnology
Background:
- Advanced technologies enable detailed investigation of molecular interactions in cancer.
- Genomic discoveries have identified numerous potential drug targets.
- Current research and development face bottlenecks due to the extensive analysis required for these targets.
Purpose of the Study:
- To review emerging high-throughput technologies for analyzing cancer-related molecular information.
- To discuss the application of DNA, tissue, and live-cell transfection microarrays.
- To explore how these technologies can accelerate the translation of genomic data.
Main Methods:
- Review of current literature on high-throughput technologies.
- Examination of DNA, tissue, and live-cell transfection microarray applications.
- Analysis of processes for discovering, validating, and translating genomic information.
Main Results:
- High-throughput technologies offer solutions to the bottleneck in functional analysis of cancer targets.
- Microarray technologies can efficiently process large volumes of data from genomic studies.
- These methods facilitate the discovery, validation, and translation of cancer-related genetic information.
Conclusions:
- Emerging microarray technologies are crucial for overcoming challenges in cancer drug development.
- Efficient data processing via high-throughput methods is essential for utilizing genomic project outcomes.
- These technologies promise to accelerate the identification and validation of novel cancer drug targets.